Page last updated: 2024-10-29

isoproterenol and Anemia, Hypochromic

isoproterenol has been researched along with Anemia, Hypochromic in 5 studies

Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.

Anemia, Hypochromic: Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)

Research Excerpts

ExcerptRelevanceReference
"Resistance to isoproterenol-induced cardiac necrosis (IPRO) was compared in rats exposed to two types of hypoxia (i."3.65Experimental cardiac necrosis in hypobaric and anemic hypoxia. ( McGrath, JJ; Ostádal, B; Procházka, J; Rychterova, V; Wachtlova, M, 1975)
" Cardiomegaly has been produced in rats by sideropenic anaemia, by isoprenaline or thyroxine or by the application of both drugs, by artificial increase in resistance to blood flow and by long-term adaptation to hypoxia and physical stress."3.65The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly. ( Bartosová, D; Chvapil, M; Korecký, B; Poupa, O; Rakusan, K; Turek, Z; Vízek, M, 1969)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sung, R1
Stephens, M1
Blayney, L1
Henderson, A1
Eriksson, H1
Svärd, PO1
McGrath, JJ1
Ostádal, B1
Procházka, J1
Wachtlova, M1
Rychterova, V1
Bartosová, D1
Chvapil, M1
Korecký, B1
Poupa, O1
Rakusan, K1
Turek, Z1
Vízek, M1
Knieriem, HJ1

Reviews

1 review available for isoproterenol and Anemia, Hypochromic

ArticleYear
[Morphological principles of cardiac hypertrophy].
    Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung, 1972, Volume: 38

    Topics: Adult; Anemia, Hypochromic; Animals; Cardiomegaly; Cardiomyopathies; Cardiomyopathy, Hypertrophic; C

1972

Other Studies

4 other studies available for isoproterenol and Anemia, Hypochromic

ArticleYear
Cardiac hypertrophy and its regression in rat: comparison of morphological changes in response to aortic constriction, iron deficiency anaemia and isoprenaline.
    Journal of molecular and cellular cardiology, 1982, Volume: 14, Issue:9

    Topics: Anemia, Hypochromic; Animals; Aorta, Abdominal; Body Water; Cardiomegaly; Constriction; Isoprotereno

1982
Pharmacological studies on an iron-poly-(sorbitol-gluconic acid) complex for parenteral treatment of iron deficiency anaemia.
    Scandinavian journal of haematology. Supplementum, 1977, Volume: 32

    Topics: Acetylcholine; Anemia, Hypochromic; Animals; Blood Coagulation; Blood Pressure; Cardiovascular Syste

1977
Experimental cardiac necrosis in hypobaric and anemic hypoxia.
    Journal of applied physiology, 1975, Volume: 39, Issue:2

    Topics: Anemia, Hypochromic; Animals; Atmosphere Exposure Chambers; Hemoglobins; Hypoxia; Injections, Subcut

1975
The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly.
    The Journal of physiology, 1969, Volume: 200, Issue:2

    Topics: Anemia, Hypochromic; Animals; Cardiomegaly; Collagen; Hydroxyproline; Hypertension; Hypertrophy; Hyp

1969